Viridian Therapeutics (VRDN)
NASDAQ:VRDN
Holding VRDN?
Track your performance easily

Viridian Therapeutics (VRDN) Financial Statements

1,036 Followers

Viridian Therapeutics Financial Overview

Viridian Therapeutics's market cap is currently ―. The company's EPS TTM is $-4.505; its P/E ratio is -3.26; Viridian Therapeutics is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.87. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 72.00K$ 72.00K$ 72.00K$ 72.00K-
Gross Profit$ 72.00K$ 72.00K$ 72.00K$ 72.00K-
EBIT$ -47.95M$ -65.94M$ -47.06M$ -54.86M$ -68.35M
EBITDA$ -47.81M$ -65.79M$ -49.38M-$ -71.17M
Net Income Common Stockholders$ -48.54M$ -66.86M$ -47.66M$ -55.06M$ -68.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 521.55M$ 374.54M$ 201.41M$ 334.29M$ 373.86M
Total Assets$ 630.38M$ 490.42M$ 328.76M$ 351.47M$ 386.64M
Total Debt$ 20.33M$ 20.20M$ 20.00M$ 4.71M$ 4.68M
Net Debt$ -501.22M$ -354.34M$ -181.41M$ -329.58M$ -369.18M
Total Liabilities$ 47.85M$ 48.40M$ 45.18M$ 35.61M$ 36.09M
Stockholders Equity$ 454.25M$ 442.02M$ 283.58M$ 315.86M$ 350.55M
Cash Flow-
Free Cash Flow$ -45.22M$ -38.05M$ -39.39M-$ -62.09M
Operating Cash Flow$ -45.22M$ -38.00M$ -38.98M-$ -61.97M
Investing Cash Flow$ -143.04M$ -169.71M$ 48.04M-$ -13.29M
Financing Cash Flow$ 177.08M$ 198.94M$ 15.46M-$ 8.20M
Currency in USD

Viridian Therapeutics Earnings and Revenue History

Viridian Therapeutics Debt to Assets

Viridian Therapeutics Cash Flow

Viridian Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis